Follow

Submissions from 2025

Link

A Comparison of Large Language Model Powered Search Tools Reveal Differences in Output Quality, Information Transparency, and Accessibility for Mohs Micrographic Surgery Inquiries, Neil K. Jairath, Sumanth Chennareddy, Sophia Manduca, Adriana Lopez, Murad Alam, Nicholas Golda, Elise Ng, Vishal A. Patel, Emily S. Ruiz, Joshua W. Trufant, and Jesse M. Lewin

Link

Factors Influencing Treatment Adherence in Chronic Spontaneous Urticaria: A Systematic Review, Aditya Joshi, Lauren Gawey, Muhammad Rahman, Raveena Ghanshani, Khiem A. Tran, Adam Friedman, Jennifer L. Hsiao, and Vivian Y. Shi

Link

Consensus Statement on the Prevention and Management of Complications of Fully Ablative Laser Resurfacing of the Face, Bianca Y. Kang, Joel L. Cohen, Roy Geronemus, Suzanne L. Kilmer, Edward Victor Ross, Elizabeth L. Tanzi, Jill S. Waibel, Brian J. Wong, Murad Alam, Macrene Alexiades, Kenneth A. Arndt, Mathew Avram, Ashish C. Bhatia, Brian Stuart Biesman, Jason D. Bloom, A Jay Burns, Henry H. Chan, Catherine M. DiGiorgio, Jeffrey S. Dover, Sam Fathizadeh, Sara C. Esteves, Michael H. Gold, Gerald N. Goldberg, Merete Haedersdal, Elika Hoss, Omar A. Ibrahimi, H Ray Jalian, Kristen M. Kelly, Woraphong Manuskiatti, Lisa A. Marks, Girish S. Munavalli, and Jason N. Pozner

Link

Real-world Evidence of Brodalumab Safety for the Treatment of Psoriasis, Mark Lebwohl, Eingun James Song, Tina Bhutani, Lawrence Green, and Abby Jacobson

Link

The Association Between Atopic Dermatitis and Select Disease Events in Adults in the United States: A Retrospective Cohort Study in the Optum Electronic Health Records Database, Adina R. Lemeshow, Alexander Egeberg, Thomas Edwards, Stephen E. Schachterle, William Romero, Daniela E. Myers, Shefali Vyas, and Jonathan I. Silverberg

Link

Successful treatment of recalcitrant amyopathic dermatomyositis with deucravacitinib in addition to intravenous immunoglobulin, Megan E. McNamara and Leonardo Tjahjono

Link

Gene Expression Profiling (GEP) in Dermatology, Part 1: Introduction, Development, Benefits, Limitations, and Future Directions of GEP, Sino Mehrmal, Marcus G. Tan, Sarah T. Arron, John A. Carucci, Clay J. Cockerell, Aaron R. Mangold, Vishal A. Patel, Mark R. Pittelkow, Emily S. Ruiz, Ashley Wysong, and Stanislav N. Tolkachjov

Link

What Does Long-Term Control in Atopic Dermatitis Look Like?, Shanthi Narla, Zelma C. Chiesa Fuxench, Katrina Abuabara, Lisa A. Beck, Raj Chovatiya, Diamant Thaçi, and Jonathan I. Silverberg

Link

Current updates in the epidemiology and comorbidities of atopic dermatitis, Shanthi Narla and Jonathan I. Silverberg

Link

Efficacy and Safety of Ruxolitinib Cream Combined With Narrow-Band UVB Phototherapy for Treatment of Vitiligo, Amit G. Pandya, Charles W. Lynde, Maryam Shayesteh Alam, Ira H. Thorla, Katherine Reed, Lawrence J. Green, Babak Soltanalizadeh, Diana Stefani-Hunyady, Deanna Kornacki, and Mark S. Amster

Link

The Effectiveness of an Educational Intervention to Introduce Adolescents From Marginalized Backgrounds to Dermatology: A Pilot Initiative, Heli Patel, Hrushikesh Patel, Ross O'Hagan, Robert Smith, Adam Friedman, Rishab Revankar, Pamela Allen, and Seemal R. Desai

A Review of Glucagon-like Peptide-1 in Dermatology, Willmar Patino, Amanda Thomas, Sanjana Jain, James Q. Del Rosso, and Naiem T. Issa

Link

A Scoping Review of Pruritic Papular Eruption in People Living With HIV, Vincent Pecora, Yagiz Matthew Akiska, and Adam Friedman

Link

Treatment of Port Wine Birthmark With Nude Tattoo Using Multiple Laser Modalities, Vincent Pecora, Emily Murphy, and Pooja Sodha

Link

Adjuvant Cemiplimab or Placebo in High-Risk Cutaneous Squamous-Cell Carcinoma, Danny Rischin, Sandro Porceddu, Fiona Day, Daniel P. Brungs, Hayden Christie, James E. Jackson, Brian N. Stein, Yungpo Bernard Su, Rahul Ladwa, Gerard Adams, Samantha E. Bowyer, Zulfiquer Otty, Naoya Yamazaki, Paolo Bossi, Amarnath Challapalli, Axel Hauschild, Annette M. Lim, Vishal A. Patel, Joanna L. Walker, Maite De Liz Vassen Schurmann, Paola Queirolo, Javier Cañueto, Flavio Augusto Ferreira da Silva, Alexander Stratigos, Alexander Guminski, Charles Lin, Fernanda Damian, Lukas Flatz, Anne E. Taylor, David R. Carr, Samuel Harris, and Dmitry Kirtbaya

Link

Consensus on core domains for hand eczema trials: Signs, symptoms, control and quality of life, Henriette Rönsch, Karl Philipp Drewitz, Amber Reck Atwater, Detlef Becker, Philipp Bentz, Richard Brans, Tricia Chong, Heinrich Dickel, Peter Elsner, Ana M. Giménez-Arnau, Fabrizio Guarneri, María Graciela Guzmán Perera, Sarah Ibrahim, Dimitra Koumaki, Jamie Koelbel, Francesca Larese Filon, Suzana Ljubojević Hadžavdić, Laura Loman, Mihaly Matura, Sonja Molin, Robert Ofenloch, Katharina Piontek, Radoslaw Spiewak, Anne Strunk, Margo Reeder, David Reissig, Thomas Rustemeyer, Marie-Louise Schuttelaar, Dagmar Simon, Manon Sloot, Markus F. Steiner, and Saïda Tongalaza

Link

Choice of new treatment for patients with atopic dermatitis is associated with insurance status rather than race: A cross sectional study from commercial and Medicaid insurance claims databases, Maria C. Schneeweiss, Robert J. Glynn, Priyanka Anand, Yinzhu Jin, Joan Landon, and Jonathan I. Silverberg

Link

Suicidal ideation in patients with atopic dermatitis: A case-control study on 23,191 adults, Julien Seneschal, Bruno Halioua, Jerry Tan, Chaoying Gu, Thomas Luger, Roni Dodiuk-Gad, Roberto Takaoka, Flavia Pretti Aslanian, Cita Rosita Prakoeswa, Ann' Laure Demessant-Flavigny, Caroline Le Floc'h, Nabil Kerrouche, Stéphanie Merhand, Wendy Smith Begolka, África Luca de Tena Smith, Shulamit Burstein, Delphine Kerob, Charles Taieb, Charbel Skayem, Abraham Getachew Kelbore, Laurent Misery, Therdpong Tempark, Alexander Stratigos, Martin Steinhoff, and Jonathan I. Silverberg

Link

Ethical implications of ensuring follow-up care for free skin cancer screenings, Umayr R. Shaikh, Sarah H. Millan, Jeffrey M. Cohen, Jeffrey J. Miller, Adam J. Friedman, and Jane M. Grant-Kels

Link

Switching from Dupilumab to Abrocitinib in Patients with Moderate-to-Severe Atopic Dermatitis: A Podcast Article, Vivian Y. Shi, Erman Güler, Brian Esparza, and Jonathan I. Silverberg

Link

Advances in Cell-Mediated Drug Delivery for Dermatologic Diseases: Mechanisms and Current Applications, Lara Shqair, Iyla Draw, Tala Maya, Christopher G. Bunick, Hossein Akbarialiabad, Todd Schlesinger, Giovanni Damiani, Mahmoud Ghannoum, and Ayman Grada

Link

Burden of mild and moderate atopic dermatitis in adults: results from a real-world study in the United States, Jonathan I. Silverberg, Peter Anderson, Joseph C. Cappelleri, James Piercy, Mark E. Levenberg, Daniela E. Myers, and Robert A. Gerber

Link

Lebrikizumab vs Other Systemic Monotherapies for Moderate-to-Severe Atopic Dermatitis: Network Meta-analysis of Efficacy, Jonathan I. Silverberg, Thomas Bieber, Amy S. Paller, Lisa Beck, Masahiro Kamata, Luis Puig, Marni Wiseman, Khaled Ezzedine, Alan D. Irvine, Peter Foley, James Del Rosso, Linda Stein Gold, Erin Johansson, Martin Dossenbach, Gaia Gallo, Buelent Akmaz, Marta Casillas, Andrei Karlsson, Tristan Curteis, and Raj Chovatiya

Link

Lebrikizumab vs Other Systemic Monotherapies for Moderate-to-Severe Atopic Dermatitis: Network Meta-analysis of Efficacy, Jonathan I. Silverberg, Thomas Bieber, Amy S. Paller, Lisa Beck, Masahiro Kamata, Luis Puig, Marni Wiseman, Khaled Ezzedine, Alan D. Irvine, Peter Foley, James Del Rosso, Linda Stein Gold, Erin Johansson, Martin Dossenbach, Gaia Gallo, Buelent Akmaz, Marta Casillas, Andrei Karlsson, Tristan Curteis, and Raj Chovatiya

Link

Atopic dermatitis starting in childhood has a stronger impact on adults: results from the "Scars of Life" international project in 27 countries, Jonathan I. Silverberg, Roni Dodiuk-Gad, Roberto Takaoka, Jerry Tan, Chaoying Gu, Thomas Luger, Bruno Halioua, Flavia Aslanian, Cita Rosita Prakoeswa, Ann'Laure Demessant Flavigny, Caroline Le Floc'h, Nabil Kerrouche, Stéphanie Methand, Wendy Smith Begolka, África Luca Smith, Shulamit Burstein, Delphine Kerob, Charles Taieb, Charbel Skayem, Therdpong Tempark, Abraham Getachew Kelbore, Alexander Stratigos, Martin Steinhoff, Julien Seneschal, and Laurent Misery

Link

Orismilast, a PDE4B/D inhibitor, in moderate-to-severe atopic dermatitis: Efficacy and safety from a multicenter, randomized, placebo-controlled, phase 2b dose-ranging study (ADESOS), Jonathan I. Silverberg, Lawrence F. Eichenfield, Andrew Blauvelt, Alan D. Irvine, Emma Guttman-Yassky, Richard G. Langley, Richard B. Warren, Lars E. French, Jakob Felding, Anne Weiss, Claus B. Pedersen, Morten L. Jensen, Anna Carlsson, Morten O. Sommer, Kim Kjøller, and Eric L. Simpson

Link

Patients' Experiences of Atopic Dermatitis and Nemolizumab Treatment: An In-Trial Interview Study Embedded in a Phase 3 Clinical Trial (ARCADIA), Jonathan I. Silverberg, Dina Filipenko, Carla Dias Barbosa, Danielle Rodriguez, Olivier Chambenoit, Katrin Jack, Christophe Piketty, Ram Subramanian, and Jorge Puelles

Link

Achieving Optimal Treatment Targets and Minimal Disease Activity with Upadacitinib for Moderate-to-Severe Atopic Dermatitis: Integrated Analysis of Phase 3 Studies (Measure Up 1 and 2), Jonathan I. Silverberg, Melinda Gooderham, Norito Katoh, Valeria Aoki, Andrew E. Pink, Yousef Binamer, Brad Glick, Petra Staubach, Brian Calimlim, Chao Li, Ayman Grada, Alvaro Moreira, Wan-Ju Lee, and Andreas Wollenberg

Link

Impact of Achieving Optimal Treatment Targets and Minimal Disease Activity on Health-Related Quality of Life and Satisfaction in Patients with Atopic Dermatitis, Jonathan I. Silverberg, Melinda Gooderham, Andreas Wollenberg, Andrew E. Pink, Diego Ruiz Dasilva, Shawn G. Kwatra, Yousef Binamer, Norito Katoh, Valeria Aoki, Alvaro Moreira, Ayman Grada, Chao Li, Brian Calimlim, Wan-Ju Lee, and Christopher G. Bunick

Link

Atopic Dermatitis and Parental Guilt in the United States: Results of a Nationwide Study, Jonathan I. Silverberg, Delphine Kerob, Caroline Le Floc'h, Charles Taieb, Wendy Smith Begolka, Ann'Laure Demessant-Flavigny, and Charbel Skayem

Link

Psychometric Validation of the Subject Sleep Diary in Patients with Moderate-to-Severe Atopic Dermatitis, Jonathan I. Silverberg, Danielle N. Rodriguez, Carla Dias-Barbosa, Dina Filipenko, Liliana Ulianov, Christophe Piketty, and Jorge Puelles

Link

Psychometric Validation of the Subject Sleep Diary in Patients with Moderate-to-Severe Atopic Dermatitis, Jonathan I. Silverberg, Danielle N. Rodriguez, Carla Dias-Barbosa, Dina Filipenko, Liliana Ulianov, Christophe Piketty, and Jorge Puelles

Link

Prevalence, severity and predictors of hand eczema in patients treated for atopic dermatitis: a cross-sectional observational study, Jonathan I. Silverberg, Archana Samynathan, and Jacob P. Thyssen

Link

Tailoring Abrocitinib Treatment for Moderate-to-Severe Atopic Dermatitis to Patient Disease Course: A Narrative Review, Jonathan I. Silverberg, Eric Simpson, Melinda Gooderham, Stephan Weidinger, Melissa Watkins, and Justine Alderfer

Link

Switching from Dupilumab to Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of Efficacy After Treatment With Dupilumab in JADE DARE, Jonathan I. Silverberg, Eric L. Simpson, Andrew E. Pink, Stephan Weidinger, Gary Chan, Pinaki Biswas, Claire Clibborn, and Erman Güler

Link

Chronic skin conditions and life trajectories: development and validation of "Dermatology Long-Term Life Impact Measure (DLLIM)", Jonathan I. Silverberg, Charbel Skayem, Ann'Laure Demessant Flavigny, Caroline Le Floc'h, Stéphanie Methand, Wendy Smith Begolka, África Luca Smith, Shulamit Burstein, Claire Della Vedova, Emmanuel Chamorey, Delphine Kerob, Charles Taieb, and Khaled Ezzedine

Link

Nearly Half of American Children with Atopic Dermatitis Experience Significant Quality of Life Impairment, Often Underestimated by Parents, Jonathan I. Silverberg, Charbel Skayem, Caroline Le Floc'h, Wendy Smith Begolka, Charles Taieb, Ann'Laure Demessant-Flavigny, Delphine Kerob, and Andrew Y. Finlay

Link

Response to Letter to the Editor from Dr. Paul et al, Jonathan I. Silverberg, Liliana Ulianov, and Christophe Piketty

Link

Lebrikizumab provides stable skin response with no or minimal fluctuations for up to 2 years in patients with atopic dermatitis, Jonathan I. Silverberg, Andreas Wollenberg, Linda Stein Gold, Gil Yosipovitch, Peter Lio, Christian Vestergaard, Sonja Ständer, Jose Manuel Carrascosa, Gaia Gallo, Marta Casillas, Yuxin Ding, Fan Emily Yang, Evangeline Pierce, Helena Agell, and James Del Rosso

Link

Long-Term Safety and Efficacy with Roflumilast Cream 0.15% in Patients Aged ≥6 Years with Atopic Dermatitis: A Phase 3 Open-Label Extension Trial, Eric L. Simpson, Lawrence F. Eichenfield, Kim A. Papp, Seth B. Forman, Adelaide A. Hebert, Mercedes E. Gonzalez, Melinda J. Gooderham, H Chih-Ho Hong, Vimal H. Prajapati, Emma Guttman-Yassky, Jonathan I. Silverberg, Melissa S. Seal, David Krupa, Erin Almaraz, Diane Hanna, Patrick Burnett, Scott Snyder, David H. Chu, Robert C. Higham, and David R. Berk

Link

Do Allergic Comorbidities Alter the Efficacy and Safety of Abrocitinib or Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis?, Eric L. Simpson, Jonathan I. Silverberg, Bob Geng, José-Manuel Carrascosa, Thomas Bieber, Patrick M. Brunner, Delphine Staumont-Sallé, Chao Ji, Pinaki Biswas, Claire Feeney, Irene Hernández-Martín, Francisco José Rebollo Laserna, and Herwig Koppensteiner

Link

Rapid Itch Improvement and Skin Clearance with Upadacitinib Versus Placebo (Measure Up 1 and Measure Up 2) and Versus Dupilumab (Heads Up): Results from Three Phase 3 Clinical Trials in Patients with Moderate-to-Severe Atopic Dermatitis, Eric L. Simpson, Jonathan I. Silverberg, Vimal H. Prajapati, Kilian Eyerich, Norito Katoh, Mark Boguniewicz, Emma Guttman-Yassky, E James Song, Wan-Ju Lee, Henrique D. Teixeira, Tianshuang Wu, Cristina Sancho Sanchez, Namita Vigna, Brian M. Calimlim, and Marjolein de Bruin-Weller

Link

Enhanced metastatic risk stratification for Cutaneous Squamous Cell Carcinoma by combining clinical guidelines with the Erasmus MC model: Results from Two Nationwide Nested Case-Control Studies, O F. Steijlen, L Pozza, J J. Traets, B Rentroia-Pacheco, C J. Eggermont, D Bellomo, S Alex, V A. Patel, A L. Mooyaart, L M. Hollestein, and M Wakkee

Link

Response to [Zheng et al.,] "Letter to "Enhanced metastatic risk stratification for Cutaneous Squamous Cell Carcinoma by combining clinical guidelines with the Erasmus MC model".", Olivia F. Steijlen, Lara Pozza, Joleen J. Traets, Barbara Rentroia-Pacheco, Celeste J. Eggermont, Domenico Bellomo, Sheril Alex, Vishal A. Patel, Antien L. Mooyaart, Loes M. Hollestein, and Marlies Wakkee

Link

Assessing vulvar dermatology education in medical school preclinical and clinical curriculum, Kennedy H. Sun, Rachel Bernardo, Scarlett J. Bergam, Yagiz Matthew Akiska, Allison Etcheverry, and Emily Murphy

Link

Assessing vulvar dermatology education in medical school preclinical and clinical curriculum, Kennedy H. Sun, Rachel Bernardo, Scarlett J. Bergam, Yagiz Matthew Akiska, Allison Etcheverry, and Emily Murphy

Link

Perioperative Treatment Strategies for Advanced Melanoma and Non-Melanoma Skin Cancers, Kennedy H. Sun, Sach Thakker, Jonathan Greenzaid, Micah Belzberg, David M. Miller, and Vishal A. Patel

Link

Acral Lentiginous Melanoma. Part I. Epidemiology, Etiology, Clinical Presentation, and Diagnosis, Sach Thakker, Daniella Jaguan, Micah Belzberg, Nina Gulati, Janeth R. Campbell, Brittney K. DeClerck, Gino K. In, and Vishal A. Patel

Link

An Ethical Framework for Managing Neglected Skin Tumors in Older Patients, Sach Thakker, Kira Minkis, Shari R. Lipner, Nicholas Gulati, Vishal A. Patel, and Jafar Al-Mondhiry

Link

Prevalence and Characteristics of Chronic Hand Eczema Among Adults in Denmark: A General Population-Based Study, David Thein, Julia-Tatjana Maul, Simone Ribero, Jonathan I. Silverberg, Alexander Egeberg, and Jacob P. Thyssen

Link

Lichen Planus: A Cross-Sectional Evaluation of US Dermatologists' Comorbidity Screening and Management Patterns, Savanna I. Vidal, Nikita Menta, and Adam Friedman

Link

Child and Adult Seborrheic Dermatitis: A Narrative Review of the Current Treatment Landscape, Savanna I. Vidal, Nikita Menta, and Lawrence Green

Link

Child and Adult Seborrheic Dermatitis: A Narrative Review of the Current Treatment Landscape, Savanna I. Vidal, Nikita Menta, and Lawrence Green

Link

Rademikibart monotherapy for moderate-to-severe atopic dermatitis in a 1-year, randomized, phase II trial (SEASIDE CHINA): initial two-week dosing, followed by two-week or four-week dosing, Jianzhong Zhang, Jonathan I. Silverberg, Jiawang Guo, Jili Yun, Wuban Pan, Zheng Wei, and Raúl Collazo

Submissions from 2024

Link

Applications of nitric oxide-releasing nanomaterials in dermatology: Skin infections and wound healing, Sara Abdel Azim, Cleo Whiting, and Adam J. Friedman

Link

Tyrosine Kinase 2 Inhibition With Zasocitinib (TAK-279) in Psoriasis: A Randomized Clinical Trial, April W. Armstrong, Melinda Gooderham, Charles Lynde, Catherine Maari, Seth Forman, Lawrence Green, Vivian Laquer, Xinyan Zhang, Nathalie Franchimont, Esha A. Gangolli, Jessamyn Blau, Yiwei Zhao, Wenwen Zhang, Bhaskar Srivastava, Graham Heap, and Kim Papp

Link

Tyrosine Kinase 2 Inhibition With Zasocitinib (TAK-279) in Psoriasis: A Randomized Clinical Trial, April W. Armstrong, Melinda Gooderham, Charles Lynde, Catherine Maari, Seth Forman, Lawrence Green, Vivian Laquer, Xinyan Zhang, Nathalie Franchimont, Esha A. Gangolli, Jessamyn Blau, Yiwei Zhao, Wenwen Zhang, Bhaskar Srivastava, Graham Heap, and Kim Papp

Link

Efficacy of Upadacitinib and Dupilumab on Achieving Stringent and Composite Skin and Itch Outcomes: an Indirect Comparison of Adults with Moderate-to-Severe Atopic Dermatitis, April W. Armstrong, H Chih-Ho Hong, Brian M. Calimlim, Marric G. Buessing, Marjorie M. Crowell, and Jonathan I. Silverberg

Link

Efficacy of Upadacitinib and Dupilumab on Achieving Stringent and Composite Skin and Itch Outcomes: an Indirect Comparison of Adults with Moderate-to-Severe Atopic Dermatitis, April W. Armstrong, H Chih-Ho Hong, Brian M. Calimlim, Marric G. Buessing, Marjorie M. Crowell, and Jonathan I. Silverberg

Link

Evaluating the Readability of the iPledge Comprehension Assessment and its Impact on Isotretinoin Accessibility, Peter Baek, Nidhi Shah, and A Yasmine Kirkorian

Link

Roflumilast foam 0.3% for adolescent and adult patients with seborrheic dermatitis: A randomized, double-blinded, vehicle-controlled, phase 3 trial, Andrew Blauvelt, Zoe D. Draelos, Linda Stein Gold, Javier Alonso-Llamazares, Neal Bhatia, Janet DuBois, Seth B. Forman, Melinda Gooderham, Lawrence Green, Scott T. Guenthner, Adelaide A. Hebert, Edward Lain, Angela Y. Moore, Kim A. Papp, Matthew Zirwas, Saori Kato, Scott Snyder, David Krupa, Patrick Burnett, David R. Berk, and David H. Chu

Link

More Time Spent with Clear Skin and No Itch with Upadacitinib versus Dupilumab for Atopic Dermatitis, Andrew Blauvelt, Kilian Eyerich, Alan D. Irvine, Marjolein de Bruin-Weller, Shawn G. Kwatra, Melinda Gooderham, Brian Kim, Brian M. Calimlim, Wan-Ju Lee, Eliza M. Raymundo, Yingyi Liu, Sarah Ofori, Andrew M. Platt, and Jonathan I. Silverberg

Link

More Time Spent with Clear Skin and No Itch with Upadacitinib versus Dupilumab for Atopic Dermatitis, Andrew Blauvelt, Kilian Eyerich, Alan D. Irvine, Marjolein de Bruin-Weller, Shawn G. Kwatra, Melinda Gooderham, Brian Kim, Brian M. Calimlim, Wan-Ju Lee, Eliza M. Raymundo, Yingyi Liu, Sarah Ofori, Andrew M. Platt, and Jonathan I. Silverberg

Link

Cendakimab in Patients With Moderate to Severe Atopic Dermatitis: A Randomized Clinical Trial, Andrew Blauvelt, Emma Guttman-Yassky, Charles Lynde, Saakshi Khattri, Joel Schlessinger, Shinichi Imafuku, Yayoi Tada, Akimichi Morita, Marni Wiseman, Bartlomiej Kwiek, Martina Machkova, Peijin Zhang, Misti Linaberry, Jie Li, Sandra Zhang, Giovanni Franchin, Edgar D. Charles, Claudia H. De Oliveira, and Jonathan I. Silverberg

Link

Cendakimab in Patients With Moderate to Severe Atopic Dermatitis: A Randomized Clinical Trial, Andrew Blauvelt, Emma Guttman-Yassky, Charles Lynde, Saakshi Khattri, Joel Schlessinger, Shinichi Imafuku, Yayoi Tada, Akimichi Morita, Marni Wiseman, Bartlomiej Kwiek, Martina Machkova, Peijin Zhang, Misti Linaberry, Jie Li, Sandra Zhang, Giovanni Franchin, Edgar D. Charles, Claudia H. De Oliveira, and Jonathan I. Silverberg

Link

Executive summary: Consensus treatment guidelines for the use of methotrexate for inflammatory skin disease in pediatric patients, Heather A. Brandling-Bennett, Lisa M. Arkin, Yvonne E. Chiu, Adelaide A. Hebert, Jeffrey P. Callen, Leslie Castelo-Soccio, Dominic O. Co, Kelly M. Cordoro, Megan L. Curran, Austin M. Dalrymple, Carsten Flohr, Ken B. Gordon, Diane Hanna, Alan D. Irvine, Susan Kim, A Yasmine Kirkorian, Irene Lara-Corrales, Jill Lindstrom, Amy S. Paller, Melissa Reyes, Wendy Smith Begolka, Wynnis L. Tom, Abby S. Van Voorhees, Ruth Ann Vleugels, Lara Wine Lee, Olivia Davies, and Elaine C. Siegfried

Link

Association of alopecia areata and ischemic heart disease and cerebrovascular in U.S. adults: an all of us database study, Stella Caldas, Angel D. Pagan, Juliana Pulsinelli, Joel Correa da Rosa, Seungyeon Jung, Divija Sharma, Jonas A. Adalsteinsson, and Benjamin Ungar

Link

Pediatric Cutaneous T-Cell Neoplasms: Clinical and Pathological Features, Updated Classifications, and Critical Differential Diagnoses, Jinjun Cheng, Birte Wistinghausen, and A Yasmine Kirkorian

Link

Attitudes, practices, facilitators, and barriers to sexual orientation and gender identity data collection in dermatology practices, Richard Chen, Temi Adekunle, Lena Chu, Ronnie Festok, Julia L. Gao, Daniel A. Yanes, Erica D. Dommasch, John G. Zampella, and Howa Yeung

Link

Standardizing Retrospective Observational Research in Cutaneous Squamous Cell Carcinoma: Expert Panel Guidelines from ITSCC, Shayan Cheraghlou, Mary L. Stevenson, Sean R. Christensen, Jeremy S. Bordeaux, Joanna L. Walker, Divya Srivastava, Carla Ferrándiz-Pulido, Kristin P. Bibee, Joi B. Carter, Faramarz H. Samie, Vishal A. Patel, Bryan T. Carroll, Allison T. Vidimos, Christian L. Baum, Justin J. Leitenberger, Anokhi Jambusaria-Pahlajani, Emily S. Ruiz, John A. Carucci, David R. Carr, and Kathryn T. Shahwan

Link

Standardizing Retrospective Observational Research in Cutaneous Squamous Cell Carcinoma: Expert Panel Guidelines from ITSCC, Shayan Cheraghlou, Mary L. Stevenson, Sean R. Christensen, Jeremy S. Bordeaux, Joanna L. Walker, Divya Srivastava, Carla Ferrándiz-Pulido, Kristin P. Bibee, Joi B. Carter, Faramarz H. Samie, Vishal A. Patel, Bryan T. Carroll, Allison T. Vidimos, Christian L. Baum, Justin J. Leitenberger, Anokhi Jambusaria-Pahlajani, Emily S. Ruiz, John A. Carucci, David R. Carr, and Kathryn T. Shahwan

Link

Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE- and Institute of Medicine-based recommendations, Derek K. Chu, Lynda Schneider, Rachel Netahe Asiniwasis, Mark Boguniewicz, Anna De Benedetto, Kathy Ellison, Winfred T. Frazier, Matthew Greenhawt, Joey Huynh, Elaine Kim, Jennifer LeBovidge, Mary Laura Lind, Peter Lio, Stephen A. Martin, Monica O'Brien, Peck Y. Ong, Jonathan I. Silverberg, Jonathan M. Spergel, Julie Wang, Kathryn E. Wheeler, and Gordon H. Guyatt

Link

Photopatch testing: Clinical characteristics, test results, and final diagnoses from the North American Contact Dermatitis Group, 2009-2020, Vincent A. DeLeo, Brandon L. Adler, Donald V. Belsito, Melanie D. Pratt, Denis Sasseville, Margo J. Reeder, Erin M. Warshaw, Amber R. Atwater, James S. Taylor, Frances Storrs, James G. Marks, Joel G. DeKoven, Jonathan Silverberg, JiaDe Yu, Nina Botto, Marie-Claude Houle, Christen M. Mowad, and Cory A. Dunnick

Link

Isotretinoin for rosacea: A systematic review, Sapana Desai and Adam Friedman

Link

Capturing patient-reported sleep disturbance in atopic dermatitis clinical trials, Carla Dias-Barbosa, Jonathan I. Silverberg, Sonja Ständer, Danielle Rodriguez, Fatoumata Fofana, Dina Filipenko, Liliana Ulianov, Christophe Piketty, and Jorge Puelles

Link

Biologics and oral systemic treatment preferences in patients and physicians for moderate-to-severe atopic dermatitis: a discrete choice experiment in the United Kingdom and Germany, Nicholas Durno, Pablo Arija, Krystallia Pantiri, Marieke Heisen, Marco Boeri, Josef Paris, Katrin Jack, Olivier Chambenoit, Ramkumar Subramanian, Jorge Puelles, Elly Stolk, Ben van Hout, and Jonathan I. Silverberg

Link

Biologics and oral systemic treatment preferences in patients and physicians for moderate-to-severe atopic dermatitis: a discrete choice experiment in the United Kingdom and Germany, Nicholas Durno, Pablo Arija, Krystallia Pantiri, Marieke Heisen, Marco Boeri, Josef Paris, Katrin Jack, Olivier Chambenoit, Ramkumar Subramanian, Jorge Puelles, Elly Stolk, Ben van Hout, and Jonathan I. Silverberg

Link

Targeting the aryl hydrocarbon receptor as a strategy to expand the therapeutic armamentarium in atopic dermatitis, Lawrence F. Eichenfield, Jonathan I. Silverberg, Adelaide A. Hebert, and Mark Boguniewicz

Link

Efficacy, Safety, and Long-Term Disease Control of Ruxolitinib Cream Among Adolescents with Atopic Dermatitis: Pooled Results from Two Randomized Phase 3 Studies, Lawrence F. Eichenfield, Eric L. Simpson, Kim Papp, Jacek C. Szepietowski, Andrew Blauvelt, Leon Kircik, Jonathan I. Silverberg, Elaine C. Siegfried, Michael E. Kuligowski, May E. Venturanza, Howard Kallender, Haobo Ren, and Amy S. Paller

Link

Rx -to- OTC switch increased access and lowered cost of topical adapalene, William Fix, Sapana Desai, Dillon Nussbaum, and Adam Friedman

Link

A Practical Approach to Diagnosing and Managing Chronic Spontaneous Urticaria, Adam Friedman, Shawn G. Kwatra, and Gil Yosipovitch

Link

A Practical Approach to Diagnosing and Managing Chronic Spontaneous Urticaria, Adam Friedman, Shawn G. Kwatra, and Gil Yosipovitch

Link

Hailey-Hailey disease successfully treated with tralokinumab and literature review of successful treatment with dupilumab, Kareena S. Garg, Jonathan Silverberg, and Leonardo Tjahjono

Link

Treatment of recalcitrant discoid lupus erythematosus with roflumilast 0.3% cream following suboptimal response to anifrolumab and improvement of hypopigmentation, Kareena S. Garg and Leonardo A. Tjahjono

Link

Speed and Cumulative Responses According to Body Regions in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Ixekizumab (Interleukin-17A Antagonist) versus Guselkumab (Interleukin-23p19 Inhibitor), Melinda Gooderham, Ronald Vender, Jeffrey Crowley, H Chih-Ho Hong, Meghan Feely, Alyssa Garrelts, Kyoungah See, Bruce Konicek, and Lawrence Green

Efficacy and Safety of Microencapsulated Benzoyl Peroxide Cream, 5%, in Papulopustular Rosacea in Elderly Patients: Post-hoc Analysis of Results from Two Randomized, Phase III, Vehicle-controlled Trials, Lawrence J. Green, Hilary Baldwin, Jeffrey Sugarman, Bill Andriopoulos, Ori Nov, Ofra Levy-Hacham, Neal Bhatia, and William P. Werschler

Link

Response to Bass et al.'s "Significant discordance in DermTech test results when paired with histopathology: Caveat emptor.", Lawrence J. Green, Brook Brouha, and Neal Bhatia

Link

Pediatric dermatologic emergencies, Juliana R. Gruver and A Yasmine Kirkorian

Link

Pediatric dermatologic emergencies, Juliana R. Gruver and A Yasmine Kirkorian

Link

A Practical Guide to Using Oral JAK Inhibitors for Atopic Dermatitis from the International Eczema Council, Carter Haag, Andrew Alexis, Valeria Aoki, Robert Bissonnette, Andrew Blauvelt, Raj Chovatiya, Michael J. Cork, Simon G. Danby, Lawrence Eichenfield, Kilian Eyerich, Melinda Gooderham, Emma Guttman-Yassky, Dirk-Jan Hijnen, Alan Irvine, Norito Katoh, Dedee F. Murrell, Yael A. Leshem, Adriane Levin, Ida Vittrup, Jill I. Olydam, Raquel L. Orfali, Amy Paller, Yael Renert-Yuval, David Rosmarin, Jonathan Silverberg, Jacob Thyssen, Sonja Ständer, Nick Stefanovic, Gail Todd, JiaDe Yu, and Eric Simpson

Link

Use of advanced systemic therapy in patients with moderate-to-severe atopic dermatitis in the TARGET-DERM AD Registry, Michael A. Haft, Keith D. Knapp, Ami Claxton, Breda Munoz, Julie M. Crawford, Sanjeev Balu, Yestle Kim, Shannon Schneider, Dawn Z. Eichenfield, Jonathan I. Silverberg, Lawrence F. Eichenfield, Jerry Bagel, Jamie L. Rhoads, and Amy S. Paller

Link

Interventions for anxiety and depression in patients with atopic dermatitis: a systematic review and meta-analysis, Stella P. Hartono, Sheena Chatrath, Ozge N. Aktas, Stephanie A. Kubala, Korey Capozza, Ian A. Myles, Jonathan I. Silverberg, and Alan Schwartz

Link

Nonhealing vulvar ulcer associated with hyperkeratotic depigmented plaques, Shivani Jain, Sydney Rivera, Emily Murphy, and Melissa M. Mauskar

Link

Nonhealing vulvar ulcer associated with hyperkeratotic depigmented plaques, Shivani Jain, Sydney Rivera, Emily Murphy, and Melissa M. Mauskar

Link

Increased loss-of-function filaggrin gene mutation prevalence in atopic dermatitis patients across northern latitudes indicates genetic fitness: A systematic review and meta-analysis, Casper Milde Khatib, Amalie Wandel Klein-Petersen, Amalie Thorsti Rønnstad, Alexander Egeberg, Maria Oberländer Christensen, Jonathan Ian Silverberg, Simon Francis Thomsen, Alan David Irvine, and Jacob Pontoppidan Thyssen

Link

Targeted Combined Endpoint Improvement in Patient and Disease Domains in Atopic Dermatitis: A Treat-to-Target Analysis of Adults with Moderate-to-Severe Atopic Dermatitis Treated with Upadacitinib, Shawn G. Kwatra, Marjolein De Bruin-Weller, Jonathan I. Silverberg, Peter Lio, Mette Deleuran, Handan Aydin, Brian M. Calimlim, Michael C. Lane, Yingyi Liu, Sarah Ofori, and Stephan Weidinger

Link

Topical Nanoencapsulated Cannabidiol Cream as an Innovative Strategy Combatting Ultraviolet A-Induced Nuclear and Mitochondrial DNA Injury: A Pilot Randomized Clinical Study, Erika McCormick, Haowei Han, Sara Abdel Azim, Cleo Whiting, Nitish Bhamidipati, Alexi Kiss, Tatiana Efimova, Brian Berman, and Adam Friedman

Link

Insights from a joint pediatric dermatology-gynecology vulvar clinic: A retrospective study, Nikita Menta, Dillon Nussbaum, Aneka Khilnani, Tazim Dowlut-McElroy, and Kaiane A. Habeshian

Link

Atopic Dermatitis: A Disorder of both Adults and Children with Varying Longitudinal Course, Shanthi Narla and Jonathan I. Silverberg

Link

Bed Bugs, Scott A. Norton and Richard J. Pollack